Rifampicin resistance in mycobacterium tuberculosis patients using GeneXpert at Livingstone Central Hospital for the year 2015: A cross sectional explorative study
BMC Infectious Diseases Sep 28, 2017
Masenga SK, et al. - This work was designed aimed to ascertain the prevalence of rifampicin resistance in tuberculosis patients at Livingstone Central Hospital for the year 2015. As per findings, prevalence of rifampicin resistance was 5.9% and there was no statistical significant difference between being male or female. Findings thus suggested the necessity for further in-depth research and appropriate interventions (i.e close follow-up and patient care for drug resistance positive patients).
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries